Predicting Colorectal Cancer Occurrence in IBD
Patients with colonic inflammatory bowel disease (IBD) are at an increased risk of developing colorectal cancer (CRC), and are therefore enrolled into a surveillance programme aimed at detecting dysplasia or early cancer. Current surveillance programmes are guided by clinical, endoscopic or histolog...
Main Authors: | Mehmet Yalchin, Ann-Marie Baker, Trevor A. Graham, Ailsa Hart |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/12/2908 |
Similar Items
-
Incidence and risk factors of micronutrient deficiency in patients with IBD and intestinal Behçet’s disease: folate, vitamin B12, 25-OH-vitamin D, and ferritin
by: Yong Eun Park, et al.
Published: (2021-01-01) -
Risk-Benefit of IBD Drugs: A Physicians and Patients Survey
by: Ferdinando D’Amico, et al.
Published: (2023-04-01) -
Are hospitalized patients with inflammatory bowel disease at increased risk of invasive bacterial infections? Results from POLIBD 3-year cohort study
by: Jolanta Gruszecka, et al.
Published: (2021-02-01) -
Current overview of colitis-associated colorectal cancer
by: Sobczak Marta, et al.
Published: (2014-11-01) -
The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis
by: Soon Ing, et al.
Published: (2012-05-01)